Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
The purpose of this study is to find out whether temozolomide followed by nivolumab is an effective treatment for MMR-proficient colorectal cancer, while causing few or mild side effects.
Colorectal Cancer
DRUG: TMZ|DRUG: Nivolumab
response rate of TMZ followed by nivolumab in participants with MMR-proficient Colorectal Cancer, Response determined by RECIST 1.1, up to 2 years
The purpose of this study is to find out whether temozolomide followed by nivolumab is an effective treatment for MMR-proficient colorectal cancer, while causing few or mild side effects.